Cargando…
The synergy factor: a statistic to measure interactions in complex diseases
BACKGROUND: One challenge in understanding complex diseases lies in revealing the interactions between susceptibility factors, such as genetic polymorphisms and environmental exposures. There is thus a need to examine such interactions explicitly. A corollary is the need for an accessible method of...
Autores principales: | Cortina-Borja, Mario, Smith, A David, Combarros, Onofre, Lehmann, Donald J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706251/ https://www.ncbi.nlm.nih.gov/pubmed/19527493 http://dx.doi.org/10.1186/1756-0500-2-105 |
Ejemplares similares
-
Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease
por: Combarros, Onofre, et al.
Publicado: (2009) -
Modelling psychiatric measures using Skew-Normal distributions
por: Counsell, N., et al.
Publicado: (2011) -
Reference range: Which statistical intervals to use?
por: Liu, Wei, et al.
Publicado: (2020) -
Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal
Hyperplasia
por: Koike, Marcia Kiyomi
Publicado: (2019) -
The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project
por: Combarros, Onofre, et al.
Publicado: (2010)